Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course
ICI-associated vasculitis are rare, heterogeneous, but can be severe requiring urgent multidisciplinary management with aggressive treatment.
Authors
- R. Outh (ORCID: https://orcid.org/0000-0001-6411-884X)
- Alejandra Flores-Chávez
- Nihan Acar‐Denizli (ORCID: https://orcid.org/0000-0002-0012-8632)
- F. Closs-Prophette
- Marie Kostine (ORCID: https://orcid.org/0000-0002-6729-6200)
- Sabine Messayke (ORCID: https://orcid.org/0000-0001-8380-4941)
- Ángel Robles‐Marhuenda (ORCID: https://orcid.org/0000-0003-1156-2570)
- J.D. Karam (ORCID: https://orcid.org/0000-0001-8583-6496)
- Munther A. Khamashta (ORCID: https://orcid.org/0000-0002-8927-6024)
- Manuel Ramos‐Casals (ORCID: https://orcid.org/0000-0001-5709-6734)
- Arianne Laparra
- Timothy R. D. J. Radstake (ORCID: https://orcid.org/0000-0003-1241-6911)
- Rakiba Belkhir
- Clifton O Bingham
- Chiara Baldini (ORCID: https://orcid.org/0000-0002-4454-1824)
- Maria Eugenia Suarez-Almazor (ORCID: https://orcid.org/0000-0001-5381-5797)
- Leonard Calabrese
- Thierry Schaeverbeke (ORCID: https://orcid.org/0000-0002-6976-643X)
- Pilar Brito‐Zerón (ORCID: https://orcid.org/0000-0003-1016-5055)
- Hendrik Schulze‐Koops (ORCID: https://orcid.org/0000-0002-1681-491X)
- Karolina Gente (ORCID: https://orcid.org/0000-0003-4544-2753)
- Jean‐Marie Michot (ORCID: https://orcid.org/0000-0003-3482-3331)
- Olivier Lambotte (ORCID: https://orcid.org/0000-0003-4425-8516)
- Alexandre Galvagni
- Karijn P.M. Suijkerbuijk (ORCID: https://orcid.org/0000-0003-3604-5430)
- Caroline Robert (ORCID: https://orcid.org/0000-0002-9493-0238)
- Juan Ignacio Ruiz (ORCID: https://orcid.org/0000-0002-0885-134X)
- José Salvador García Morillo (ORCID: https://orcid.org/0000-0003-1311-5483)
- Jacques‐Eric Gottenberg (ORCID: https://orcid.org/0000-0002-9469-946X)
- Xavier Mariette
- Philippe Kerschen
- Anne Laure Voisin
- N. Chanson (ORCID: https://orcid.org/0000-0003-1019-8076)
- O. Lambotte
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Inserm (FR)
- Centre Hospitalier de Luxembourg (LU)
- Utrecht University (NL)
- Heidelberg University (DE)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Université Paris-Saclay (FR)
- Hospital Universitario La Paz (ES)
- Institut Gustave Roussy (FR)
- University Hospital Heidelberg (DE)
- University Medical Center Utrecht (NL)
- Centre Hospitalier de Perpignan (FR)
- Centre Hospitalier Universitaire Amiens-Picardie (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hospital Clínic de Barcelona (ES)
- Centre Hospitalier du Mans (FR)
- Cancer Genomics Centre (NL)
- CEA Paris-Saclay (FR)
- Infectious Disease Models and Innovative Therapies (FR)
- Hospital Universitario Virgen del Rocío (ES)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Bicêtre Hospital (FR)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1093/rheumatology/keae711
- Citations
- 8
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 2.26
Funders
- Université Paris-Saclay
- Assistance publique-Hôpitaux de Paris